Serum and Urinary Estrone Sulfate during the Menstrual Cycle, Measured by a Direct Radioimmunoassay, and Fate of Exogenously Injected Estrone Sulfate

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Serum and early-morning urinary levels of estrone sulfate during the menstrual cycle were measured by a direct radioimmunoassay without hydrolysis. These levels were high and showed prominent peaks [serum, 2.67 ± 0.37 ng/ml (mean ± SE); urine, 5.82 ± 2.3 µg/l] around the day of the preovulatory estradiol-17β peak, and increased again during the luteal phase. Following intravenous injection of estrone sulfate, serum estrone sulfate, estrone and estradiol-17β were measured. The conversion of estrone sulfate to estrone and/or estradiol-17β was very small during their transit in the general circulation.

Related collections

Author and article information

Journal

Journal ID (publisher-id): HRE

Journal ID (nlm-ta): Horm Res Paediatr

Journal ID (doi): 10.1159/issn.1663-2818

Title: Hormone Research in Paediatrics

Publisher: S. Karger AG

ISSN (Print): 1663-2818

ISSN (Electronic): 1663-2826

Publication date Subscription-year: 1987

Publication date (Print): 1987

Publication date (Electronic): 28 November 2008

Volume: 27

Issue: 2

Pages: 61-68

Affiliations

^aDepartment of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Kyoto; ^bPharmaceutical Institute, Tohoku University, Sendai, Japan

Article

Publisher ID: 180788 Other ID: Horm Res 1987;27:61–68

DOI: 10.1159/000180788

PubMed ID: 3653846

SO-VID: d2352b78-7362-479a-8f00-7ff368fc874f

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

History

Date received : 16 September 1986

Date accepted : 12 January 1987

Page count

Pages: 8

Serum and Urinary Estrone Sulfate during the Menstrual Cycle, Measured by a Direct Radioimmunoassay, and Fate of Exogenously Injected Estrone Sulfate

Read this article at

Abstract

Related collections

Karger: Endocrinology

Author and article information

Journal

Affiliations

Article

History

Page count

Categories

Comments

Comment on this article

Similar content 90

Cited by 1